February 16, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: This week in Drug Discovery (19 – 23 January) 
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Drug development > This week in Drug Discovery (19 – 23 January) 
Drug development

This week in Drug Discovery (19 – 23 January) 

By Newsroom
Last updated: January 25, 2026
1 Min Read
Share


News round-up for 19 – 23 January by Bruno Quinney, Content Team at DDW. 

This week in DDW, innovative therapies have shown encouraging results in tackling melanoma and concussion. Elsewhere, a UK-Canadian partnership looks to advance vaccine technology. 

The top stories: 

 

Combination therapy could slash melanoma mortality risk 

An investigational mRNA-based individualised neoantigen therapy (INT) reduced the risk of high-risk melanoma recurrence or death by 49% when combined…



Source link

TAGGED:CanadaCell and gene therapyClinical trialConcussionELRIGEuropean Medicines AgencyMelanomaMerckModernaOxeia BiopharmaceuticalsregulatoryUKVaccines
Share This Article
Facebook Email Copy Link Print

HOT NEWS

Nestlé sold treated water as ‘natural’ in alleged marketing fraud

Environmental Science
May 23, 2025

This week in Drug Discovery (9 – 13 February) 

News round-up for 9 – 13 February by Bruno Quinney, Content Team at DDW. This week in DDW, researchers have…

February 15, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Certara Introduces CRF Creator Module in Pinnacle 21®

New module streamlines standardized CRF (case report form) design and EDC build to help clinical teams start studies faster.  …

Drug development
February 8, 2026

Sanofi opens $130M hub in New Jersey as part of $20B U.S. investment push

Sanofi has officially opened its new $130 million flagship corporate offices in Morristown, New Jersey. The move consolidates nearly 2,000…

Drug development
May 23, 2025

How Press Release Distribution Enhances the Process of Drug Development

The drug development process is a complex and lengthy endeavor that involves research, clinical trials, regulatory approvals, and commercialization. Given…

Drug development
April 9, 2025

2024’s blockbusters: Top 25 drugs by sales

In 2024, Merck’s Keytruda continued to dominate with $29.5 billion in sales, growing 18% over 2023’s $25 billion in sales.…

Drug development
April 5, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

This week in Drug Discovery (9 – 13 February) 
February 15, 2026
2025 Organic Chemistry Frontiers Most-Popular Articles – Organic Chemistry Frontiers Blog
February 15, 2026
HHS seeks feedback on 340B rebate model
February 15, 2026
Spider Silk Is Stronger Than Steel and Now We Know Why
February 15, 2026

Life Science Magazines

Why Open-Source Models Matter for Computational Drug Discovery
February 13, 2026
Lentiviral Tools for Cellular Engineering
February 13, 2026
How the World's Top 10 Life Sciences Companies Use AI to…
February 11, 2026
Hit Identification: How to Choose the Optimal Strategy for…
February 10, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?